Penserra Capital Management LLC Intra Cellular Therapies, Inc. Transaction History

Penserra Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $275,947 - $438,291	5,951 New	5,951 $426,000
Q1 2023 Apr 24, 2023	BUY	$43.8 - $56.99 $301,168 - $391,863	6,876 New	6,876 $372,000
Q4 2021 Feb 15, 2022	SELL	$35.2 - $53.42 $65,472 - $99,361	-1,860 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $287 - $424	10 Added 0.54%	1,860 $69,000
Q2 2021 Aug 12, 2021	BUY	$29.3 - $44.5 $586 - $890	20 Added 1.09%	1,850 $75,000
Q1 2021 May 13, 2021	SELL	$30.8 - $39.51 $308 - $395	-10 Reduced 0.54%	1,830 $62,000
Q4 2020 Feb 12, 2021	BUY	$23.34 - $32.22 $29,548 - $40,790	1,266 Added 220.56%	1,840 $58,000
Q3 2020 Nov 13, 2020	BUY	$17.61 - $31.86 $10,108 - $18,287	574 New	574 $14,000

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.92B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.